Aha1/Hsp90-IN-1

Modify Date: 2024-01-30 19:17:40

Aha1/Hsp90-IN-1 structure	Common Name	Aha1/Hsp90-IN-1
	CAS Number	2768265-58-1	Molecular Weight	426.39
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₂₂H₁₇F₃N₄O₂	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of Aha1/Hsp90-IN-1

Aha1/Hsp90-IN-1 (Compound 17) is an Aha1/Hsp90 complex inhibitor. Aha1/Hsp90-IN-1 disrupts Aha1/Hsp90 interactions with an IC50 of 3.32 μM. Aha1/Hsp90-IN-1 inhibits tau aggregation[1].

Name	Aha1/Hsp90-IN-1

Description	Aha1/Hsp90-IN-1 (Compound 17) is an Aha1/Hsp90 complex inhibitor. Aha1/Hsp90-IN-1 disrupts Aha1/Hsp90 interactions with an IC50 of 3.32 μM. Aha1/Hsp90-IN-1 inhibits tau aggregation[1].
Related Catalog	Signaling Pathways >> Cell Cycle/DNA Damage >> Microtubule/Tubulin Research Areas >> Inflammation/Immunology Signaling Pathways >> Cytoskeleton >> Microtubule/Tubulin Research Areas >> Neurological Disease
Target	IC50: 3.32 μM (Aha1/Hsp90 interactions)[1]
In Vitro	Aha1/Hsp90-IN-1 (Compound 17) (10 μM; 24 h) disrupts the Aha1/Hsp90 complex without direct inhibition of Hsp90 protein folding activity[1]. Western Blot Analysis[1] Cell Line: SH-SY5Y neuroblastoma cells and Her2 overexpressing SK-BR-3 breast cancer cells Concentration: 10 μM Incubation Time: 24 h Result: Exhibited the ability to disrupt interactions between Aha1 and Hsp90. Did not induce the degradation of Hsp90 client proteins Her2 (in SK-BR-3 cells), Cdk6, or pAktS473 (in SH SY5Y cells), nor do they induce the expression of Hsp70, a marker of the heat shock response.
References	[1]. Keegan BM, et al. Synthesis and Evaluation of Small Molecule Disruptors of the Aha1/Hsp90 Complex for the Reduction of Tau Aggregation. ACS Med Chem Lett. 2022 Apr 15;13(5):827-832.

Molecular Formula	C₂₂H₁₇F₃N₄O₂
Molecular Weight	426.39